Search Results
Slidesets
Pharmacological Considerations When Choosing Optimal Treatment Regimen - Marta Boffito, MD, PhD, FRCP
Presented at:
GCC HIV Clinical Forum 2022
Abstracts
Cost-utility analysis of dolutegravir- versus efavirenz 400mg-based regimen for the initial treatment of HIV-infected patients in Cameroon: 96-week results from the NAMSAL ANRS 12313 trial
M. Bousmah
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
Implications for Women's Health - Sharon Walmsley, MD, FRCPC, CM
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Clinical case: Policy implications - Meg Doherty, MD, PhD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
First Speaker Against the Proposition - François Venter, MD, FCP, PhD
Presented at:
INTEREST 2022
Abstracts
Effect of Multiple-Dose Itraconazole on the Pharmacokinetics of Single-Dose JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Volunteers
J. Vandenbossche, T. Kakuda
Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Nyaradzo Mgodi_Lecture.pdf
Presented at:
International Workshop on Adolescence, SRHR, & HIV 2024
Slidesets
Erwan Vo Quang_COLDA2024_Abstract.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2024
Slidesets
s3_African-HIVWomen2024_speaker slides_ stella Alamo.pdf
Presented at:
African Workshop on HIV & Women 2024